Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WAQAS A MALICK

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1801259569
CMS profile
8800534
Location
NEW YORK, NY

General Payments · PY2020–2024

$3,623.32

  • Reported across 63 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,799.06

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $1,187.50 1
Food and Beverage $611.56 27

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $1,736.40 25
BOSTON SCIENTIFIC CORPORATION $25.02 1
Acerta Pharma LLC $20.57 1
Amgen Inc. $17.07 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $124.02 2
PY2021 $672.52 10
PY2022 $834.26 20
PY2023 $193.46 3
PY2024 $1,799.06 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.07 10/04/2024 Food and Beverage Undisputed 01/23/2026 1117618164 CMS
AstraZeneca Pharmaceuticals LP $20.57 06/22/2024 Food and Beverage Undisputed 01/23/2026 1104515974 CMS
Boston Scientific Corporation $25.02 02/15/2024 Food and Beverage Undisputed 01/23/2026 1092272812 CMS
Novartis Pharmaceuticals Corporation $25.51 01/16/2024 Food and Beverage Undisputed 01/23/2026 1087132974 CMS
Novartis Pharmaceuticals Corporation $2.44 01/16/2024 Food and Beverage Undisputed 01/23/2026 1087132976 CMS
Novartis Pharmaceuticals Corporation $31.03 03/13/2024 Food and Beverage Undisputed 01/23/2026 1087132980 CMS
Novartis Pharmaceuticals Corporation $1.37 03/13/2024 Food and Beverage Undisputed 01/23/2026 1087132982 CMS
Novartis Pharmaceuticals Corporation $25.90 03/25/2024 Food and Beverage Undisputed 01/23/2026 1087132978 CMS
Novartis Pharmaceuticals Corporation $51.98 05/15/2024 Food and Beverage Undisputed 01/23/2026 1087132984 CMS
Novartis Pharmaceuticals Corporation $31.40 05/15/2024 Food and Beverage Undisputed 01/23/2026 1087132988 CMS
Novartis Pharmaceuticals Corporation $42.87 05/29/2024 Food and Beverage Undisputed 01/23/2026 1087132992 CMS
Novartis Pharmaceuticals Corporation $1.34 06/07/2024 Food and Beverage Undisputed 01/23/2026 1087132990 CMS
Novartis Pharmaceuticals Corporation $2.68 08/05/2024 Food and Beverage Undisputed 01/23/2026 1087133000 CMS
Novartis Pharmaceuticals Corporation $12.28 08/05/2024 Food and Beverage Undisputed 01/23/2026 1087133002 CMS
Novartis Pharmaceuticals Corporation $11.67 08/26/2024 Food and Beverage Undisputed 01/23/2026 1087133014 CMS
Novartis Pharmaceuticals Corporation $124.97 08/27/2024 Food and Beverage Undisputed 01/23/2026 1087132996 CMS
Novartis Pharmaceuticals Corporation $6.01 09/10/2024 Food and Beverage Undisputed 01/23/2026 1087133016 CMS
Novartis Pharmaceuticals Corporation $9.56 09/19/2024 Food and Beverage Undisputed 01/23/2026 1087133018 CMS
Novartis Pharmaceuticals Corporation $26.61 09/19/2024 Food and Beverage Undisputed 01/23/2026 1087133030 CMS
Novartis Pharmaceuticals Corporation $21.75 09/24/2024 Food and Beverage Undisputed 01/23/2026 1087133028 CMS
Novartis Pharmaceuticals Corporation $6.67 09/25/2024 Food and Beverage Undisputed 01/23/2026 1087133010 CMS
Novartis Pharmaceuticals Corporation $20.25 10/01/2024 Food and Beverage Undisputed 01/23/2026 1087133008 CMS
Novartis Pharmaceuticals Corporation $6.11 10/02/2024 Food and Beverage Undisputed 01/23/2026 1087133012 CMS
Novartis Pharmaceuticals Corporation $28.48 10/02/2024 Food and Beverage Undisputed 01/23/2026 1087133020 CMS
Novartis Pharmaceuticals Corporation $22.99 10/05/2024 Food and Beverage Undisputed 01/23/2026 1087133026 CMS
Novartis Pharmaceuticals Corporation $30.24 10/15/2024 Food and Beverage Undisputed 01/23/2026 1087133032 CMS
Novartis Pharmaceuticals Corporation $1,187.50 12/10/2024 Consulting Fee Undisputed 01/23/2026 1087133034 CMS
Novartis Pharmaceuticals Corporation $4.79 12/12/2024 Food and Beverage Undisputed 01/23/2026 1087133036 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.